About this journal
Aims and scope
Ophthalmic Genetics accepts original papers, review articles and short communications on the clinical and molecular genetic aspects of ocular diseases. The journal invites several types of contributions divided into sections, details below. Please ensure you are reading the full submission requirements in the
Journal metrics
Usage
- 83K annual downloads/views
Citation metrics
- 1.2 (2023) Impact Factor
- 1.4 (2023) 5 year IF
- 2.4 (2023) CiteScore (Scopus)
- Q2 CiteScore Best Quartile
- 0.610 (2023) SNIP
- 0.509 (2023) SJR
Speed/acceptance
- 43 days avg. from submission to first decision
- 81 days avg. from submission to first post-review decision
- 20 days avg. from acceptance to online publication
- 39% acceptance rate
Understanding and using journal metrics
Journal metrics can be a useful tool for readers, as well as for authors who are deciding where to submit their next manuscript for publication. However, any one metric only tells a part of the story of a journal’s quality and impact. Each metric has its limitations which means that it should never be considered in isolation, and metrics should be used to support and not replace qualitative review.
We strongly recommend that you always use a number of metrics, alongside other qualitative factors such as a journal’s aims & scope, its readership, and a review of past content published in the journal. In addition, a single article should always be assessed on its own merits and never based on the metrics of the journal it was published in.
For more details, please read the Author Services guide to understanding journal metrics.
Journal metrics in brief
Usage and acceptance rate data above are for the last full calendar year and are updated annually in February. Speed data is updated every six months, based on the prior six months. Citation metrics are updated annually mid-year. Please note that some journals do not display all of the following metrics (find out why).
- Usage: the total number of times articles in the journal were viewed by users of Taylor & Francis Online in the previous calendar year, rounded to the nearest thousand.
Citation Metrics
- Impact Factor*: the average number of citations received by articles published in the journal within a two-year window. Only journals in the Clarivate Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI), Arts and Humanities Citation Index (AHCI) and the Emerging Sources Citation Index (ESCI) have an Impact Factor.
- Impact Factor Best Quartile*: the journal’s highest subject category ranking in the Journal Citation Reports. Q1 = 25% of journals with the highest Impact Factors.
- 5 Year Impact Factor*: the average number of citations received by articles in the journal within a five-year window.
- CiteScore (Scopus)†: the average number of citations received by articles in the journal over a four-year period.
- CiteScore Best Quartile†: the journal’s highest CiteScore ranking in a Scopus subject category. Q1 = 25% of journals with the highest CiteScores.
- SNIP (Source Normalized Impact per Paper): the number of citations per paper in the journal, divided by citation potential in the field.
- SJR (Scimago Journal Rank): Average number of (weighted) citations in one year, divided by the number of articles published in the journal in the previous three years.
Speed/acceptance
- From submission to first decision: the average (median) number of days for a manuscript submitted to the journal to receive a first decision. Based on manuscripts receiving a first decision in the last six months.
- From submission to first post-review decision: the average (median) number of days for a manuscript submitted to the journal to receive a first decision if it is sent out for peer review. Based on manuscripts receiving a post-review first decision in the last six months.
- From acceptance to online publication: the average (median) number of days from acceptance of a manuscript to online publication of the Version of Record. Based on articles published in the last six months.
- Acceptance rate: articles accepted for publication by the journal in the previous calendar year as percentage of all papers receiving a final decision.
For more details on the data above, please read the Author Services guide to understanding journal metrics.
*Copyright: Journal Citation Reports®, Clarivate Analytics
†Copyright: CiteScore™, Scopus
Editorial board
Editor-in-Chief:
Brian P. Brooks, MD, PhD - Chief, Ophthalmic Genetics & Visual Function Branch, National Eye InstituteEditor-in-Chief, Emeritus:
Elias I. Traboulsi, MD - The Center for Genetic Eye Diseases, The Cleveland Clinic Eye InstituteAssociate Editors :
Andreas Gal (Topic: Mutation Reports) - Hamburg, Germany
Stephanie Hagstrom, PhD - Cleveland Clinic, OH, USA
Virginia Miraldi Utz, MD - Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA
Natario L. Couser, MD, MS - Virginia Commonwealth University School of Medicine, VA, USA
Arlene Drack, MD - University of Iowa, IA, USA
Editorial Board:
Mary E. Aronow - Massachusetts Eye and Ear, Boston, MA, USA
Jesse L. Berry - Keck School of Medicine of USC, Los Angeles, CA, USA
Brian P. Brooks - The National Eye Institute, Bethesda, MD, USA
Fred K. Chen - The University of Western Australia, Perth, Australia
Meghan DeBenedictis - Cleveland Clinic Cole Eye Institute, Cleveland, OH, USA
Razek G. Coussa - Dean McGee Eye Institute, Oklahoma City, Oklahoma, USA
Helene Dollfus - Université de Strasbourg, Strasbourg, France
Arlene Drack - University of Iowa, Iowa City, IA, USA
John Fingert - University of Iowa, Iowa City, IA, USA
Stephanie A. Hagstrom - Cleveland Clinic, Cleveland, OH, USA
Alex Hewitt - Melbourne School of Health Sciences, East Melbourne, Australia
Yoshihiro Hotta - Hamamatsu University School of Medicine, Hamamatsu, Japan
Robert B. Hufnagel - National Institutes of Health - Bethesda, MD, USA
Zi-Bing Jin - Wenzhou Medical University, Wenzhou, China
Ulrich Kellner - Sieberg Eye Center, Siegberg, Germany
Arif O. Khan - Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates
Robert Koenekoop - McGill University Health Centre, Montreal, Canada
Bart Leroy - Ghent University, Ghent Belgium
Richard A. Lewis - Cullen Eye Institute, Houston, TX, USA
Dietmar Lohmann - University Hospital Essen, Essen, Germany
Birgit Lorenz - Justus-Liebig University Giessen, Giessen, Germany
David Mackey - University of Western Australia, Perth, Australia
Irene Hussels Maumenee - Columbia University, New York, NY, USA
Anthony T. Moore - University College London, London, United Kingdom
Francis Munier (Topic: Retinoblastoma Research) - University of Lausanne Medical School, Lausanne, Switzerland
Mark Pennesi - Oregon Health & Science University, Portland, OR, USA
Markus Preising - Justus-Liebig University Giessen, Giessen, Germany
Anthony Robson - Moorfields Eye Hospital, London, United Kingdom
Juliana Salloum- University of Sao Paulo, Sao Paolo, Brazil
Mansoor Sarfarazi - University of Connecticut Health, Farmington, CT, USA
Lisa A. Schimmenti - Mayo Clinic Alix School of Medicine, MN, USA
Daniel Schorderet - Institut de Recherche en Ophtalmologie, Sion, Switzerland
Anne Slavotinek - Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA
Stephen Tsang - Columbia University, New York, NY, USA
Andrea Vincent - University of Auckland, Auckland, New Zealand
Nan-Kai Wang - National Taiwan University, Linkou, Taiwan
Natario L. Couser - Virginia, USA
Updated 17-11-2023
Abstracting and indexing
• De Gruyter Saur; IBZ - Internationale Bibliographie der Geistes- und Sozialwissenschaftlichen Zeitschriftenliteratur, Internationale Bibliographie der Rezensionen Geistes- und Sozialwissenschaftlicher Literatur
• EBSCOhost
• EMBASE, Priority
• Scopus
• MetaPress
• National Library of Medicine; PubMed/MEDLINE
• OCLC
• Personal Alert (E-mail)
• ProQuest
• Thomson Reuters; Current Contents, Science Citation Index Expanded, Web of Science
Open access
Ophthalmic Genetics is a hybrid open access journal that is part of our Open Select publishing program, giving you the option to publish open access. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research.
Why choose open access?
- Increase the discoverability and readership of your article
- Make an impact and reach new readers, not just those with easy access to a research library
- Freely share your work with anyone, anywhere
- Comply with funding mandates and meet the requirements of your institution, employer or funder
- Rigorous peer review for every open access article
Article Publishing Charges (APC)
If you choose to publish open access in this journal you may be asked to pay an Article Publishing Charge (APC). You may be able to publish your article at no cost to yourself or with a reduced APC if your institution or research funder has an open access agreement or membership with Taylor & Francis.
Use our APC finder to calculate your article publishing charge
Society information
Ophthalmic Genetics is the official Journal of the International Society for Genetic Eye Diseases and Retinoblastoma.
Mission Statement
To bring together individuals interested in the field of genetic diseases of the eye and in Retinoblastoma,
To provide a forum for researchers in the field of genetic diseases of the eye to share information,
To promote international collaborations in the study of genetic diseases of the eye and in Retinoblastoma,
To disseminate scientific knowledge through international conferences and through its official publication, Ophthalmic Genetics.
6 issues per year
Currently known as:
- Ophthalmic Genetics (1994 - current)
Formerly known as
- Ophthalmic Paediatrics and Genetics (1981 - 1993)
Advertising information
Would you like to advertise in Ophthalmic Genetics?
Reach an engaged target audience and position your brand alongside authoritative peer-reviewed research by advertising in Ophthalmic Genetics.
Taylor & Francis make every effort to ensure the accuracy of all the information (the "Content") contained in our publications. However, Taylor & Francis, our agents (including the editor, any member of the editorial team or editorial board, and any guest editors), and our licensors, make no representations or warranties whatsoever as to the accuracy, completeness, or suitability for any purpose of the Content. Any opinions and views expressed in this publication are the opinions and views of the authors, and are not the views of or endorsed by Taylor & Francis. The accuracy of the Content should not be relied upon and should be independently verified with primary sources of information. Taylor & Francis shall not be liable for any losses, actions, claims, proceedings, demands, costs, expenses, damages, and other liabilities whatsoever or howsoever caused arising directly or indirectly in connection with, in relation to, or arising out of the use of the Content. Terms & Conditions of access and use can be found at http://www.tandfonline.com/page/terms-and-conditions .
Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site (link opens in a new window) Instructions for authors